| |
 |
Submit to trace archives and INSDC |
|
 |
Investigation type (i.e., report type) |
|
 |
Project name |
|
| |
 |
Study |
|
| |
 |
Environment |
|
| |
 |
Geographic location (latitude and longitude (float (point, transect and region)), depth and altitude of sample (integer) |
 |
Time of sample collection (UTC) |
 |
Habitat |
|
 |
MIMS extension: select to report a set of uniform measurements for a given habitat: |
|
| |
 |
Water body: (temperature, pH, salinity, pressure, chlorophyll, conductivity, light intensity, dissolved organic carbon (DOC), current, atmospheric data, density, alkalinity, dissolved oxygen, particulate organic carbon (POC), phosphate, nitrate, sulfates, sulfides, primary production) (integer, unit) |
|
|
|
|
| |
 |
Nucleic acid sequence source |
|
| |
 |
Subspecific genetic lineage (below lowest rank of NCBI taxonomy, which is subspecies) (e.g., serovar, biotype, ecotype) (CABRI) |
 |
Ploidy (e.g., allopolyploid, polyploid) (PATO) |
 |
Number of replicons (EU, BA: chromosomes (haploid count); VI: segments) (integer) |
 |
Extrachromosomal elements (integer) |
 |
Estimated size (before sequencing; to apply to all draft genomes) (integer; base pairs) |
 |
Reference for biomaterial (primary publication if isolated before genome publication; otherwise, primary genome report) (PMID or DOI) |
 |
BioSource material identifiers: (cultures of microorganisms: identifiers(alphanumeric) for two culture collections(OBI); specimens (e.g., organelles and Eukarya): voucher condition and location(CV))ll |
 |
Known pathogenicity |
 |
Biotic relationship (e.g., free-living, parasite, commensal, symbiont) (OBI) |
 |
Specific host (e.g., host taxid, unknown, environmental) (EnvO) |
 |
Host specificity or range(taxid) |
 |
Health or disease status of specific host at time of collection (e.g., alive, asymptomatic) (PATO) |
 |
Trophic level (e.g., autotroph, heterotroph) (PATO) |
 |
Propagation (phage: lytic or lysogenic; plasmid: incompatibility group) (CV) |
 |
Encoded traits (e.g., plasmid: antibiotic resistance; phage: converting genes) (CV; see caption) |
 |
Relationship to oxygen (e.g., aerobic, anaerobic) (PATO) |
 |
Isolation and growth conditions (PMID or DOI) |
 |
Biomaterial treatment (e.g., filtering of sea water) (OBI) |
 |
Volume of sample (integer) |
 |
Sampling strategy (enriched, screened, normalized) (CV) |
|
|
|
|
| |
 |
Assay |
|
| |
 |
Sequencing |
|
| |
 |
Nucleic acid preparation (extraction method(CV); amplification(CV) |
 |
Library construction (library size (integer), number of reads sequenced (integer), vector(CV) |
 |
Sequencing method (e.g., dideoxysequencing, pyrosequencing, polony) (OBI) |
 |
Assembly (assembly method (CV), estimated error rate (unit) and method of calculation (CV)) |
 |
Finishing strategy (status—e.g., complete or draft (CV), coverage (integer), contigs (integer)) |
 |
Relevant Standard Operating Procedures (SOPs) |
 |
Relevant electronic resources |
|
|
|
|
|